Advertisement
Advertisement

CERO

CERO logo

CERo Therapeutics Holdings, Inc. Common Stock

0.80
USD
+0.04
+5.30%
Apr 23, 15:59 UTC -4
Closed
exchange

After-Market

0.80

0.00
0.00%

CERo Therapeutics Holdings, Inc. Common Stock Profile

About

CERo Therapeutics Holdings Inc. is an immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. The company's lead product candidate includes CER-1236. CERo Therapeutics Holdings Inc., formerly known as Phoenix Biotech Acquisition Corp., is based in OAKLAND, Calif.

Info & Links

CEO

Chris Ehrlich

Headquarters

201 Haskins Way, Suite 230
South San Francisco, CA 94080, UNITED STATES

Sector

Medical

Auditor

Wolf & Company, P.C

Share holders

131

Employees

8

CERo Therapeutics Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.29M

Enterprise Value

966.72K

Enterprise Value/EBITDA(ttm)

-0.06

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

235.19%

Return on Assets(ttm)

-108.43%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-15.04M

Net Income Available to Common(ttm)

-11.09M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.37

52-Week Change

-99.44%

S&P 500 52-Week Change

6.00%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

5.38M

Dividend Yield

0.00%

Float4

2.48M

% Held by Insiders

18.00%

% Held by Institutions

29.64%

Balance Sheet

Total Cash(mrq)

3.33M

Total Cash Per Share(mrq)

0.62

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.50%

Quick Ratio(mrq)

0.39%

Book Value Per Share(mrq)

-0.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-22.29

Free Cash Flow(ytd)

-12.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement